Table 2 MRE HCC stiffness (kilopascals, kPa) at baseline and 6 weeks with overall survival (OS) and time-to-progression (TTP)
From: Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC
Patient | Baseline HCC stiffness (kPa) | 6 week HCC stiffness (kPa) | Difference in stiffness (kPa) | OS (weeks) | TTP (weeks) |
|---|---|---|---|---|---|
1 | 9.1 | 7 | −2.1 | 24 | 9 |
2 | 2.8 | 3.9 | 1.1 | 70 | 48 |
3 | 7.0 | 6.2 | −0.8 | 16 | – |
4 | 3.3 | 3.3 | 0 | 44 | 10 |
5 | 4.2 | 5.6 | 1.4 | 65 | 40 |
6 | 2.4 | 5.2 | 2.8 | 52 | – |
7 | 6.1 | 5.0 | −1.1 | 35 | 13 |
8 | 6.7 | 7.6 | 0.9 | 52 | 17 |
9 | 3.8 | 2.7 | −1.1 | 35 | 10 |